Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Renal tubular epithelial progenitor cells are a heterogeneous population of cells found in the developing and adult kidney that exhibit properties of self-renewal and the ability to differentiate into various types of renal epithelial cells. These cells are sometimes referred to as adult renal stem/progenitor cells (ARPCs) or scattered tubular-like cells (STCs). They can form spheroids and spontaneously generate tubule-like structures in vitro without external growth factors, recapitulating features of nephron segments such as proximal convoluted tubules, distal convoluted tubules, and the loop of Henle[1][2][4]. Markers commonly associated with these populations include CD133, CD24, vimentin, KIM1, ZO‑1, and uromodulin[3][6]. Their regenerative potential is under investigation for applications in chronic kidney disease and acute injury repair. However, there is ongoing debate about whether these represent a distinct stem/progenitor population or dedifferentiated mature epithelial cells acquiring transient regenerative capacity after injury[3][5]. No specific drugs target this population directly; rather they are studied for their role in endogenous repair mechanisms. Notes on correctness/target status: The term "Renal tubular epithelial progenitor cell population" does not refer to a single molecular target such as a receptor or enzyme but rather describes a heterogeneous group or state of cells within the kidney. It is not considered a canonical therapeutic target like an individual protein; thus "is_target" should be set to false. The entry is also flagged as "is_incorrect" because it refers to an imprecise cellular population rather than a defined molecular entity suitable for drug targeting[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Renal tubular epithelial progenitor cell.